1 not yet recruiting, 1 recruiting, 1 unknown. 3 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Bone Morphogenetic Protein 2: new trials by email Literature Review of Bone Morphogenetic Protein 2 trials Research Report on Bone Morphogenetic Protein 2
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Standard- and Micro-Dose rhBMP-2 for Implant Stability, Marginal Bone Loss, and Postoperative Sequelae: A Double-Blind Randomized Controlled Trial Standard-dose rhBMP-2, Micro-dose rhBMP-2, Sterile Normal Saline - Tooth Loss / Rehabilitation, Dental Implant | Not applicable | Not yet recruiting | University of Baghdad | 60 | 2026-12-01 | 2026-07-10 |
| Recombinant Human Bone Morphogenetic Protein-2(rhBMP-2) in Patients With Osteoporosis After Lumbar Fusion RhBMP-2 - Osteoporosis, Spinal Fusion | Not applicable | Unknown | Xijing Hospital | 76 | 2023-07-01 | 2023-06-22 |
| Comparison of Radiographic Fusion Rate and Clinical Outcome of ALIF and XLIF Performed With Either Recombinant Human Bone Morphogenetic Protein-2 or ViviGen® ViviGen®, rhBMP-2 - Spondylosis, Spondylolisthesis | Not applicable | Recruiting | Lindenhofgruppe AG | 168 | 2022-10-27 | 2026-08-26 |
Intervertebral Disc Degeneration (1) · Osteoporosis (1) · Spondylolisthesis (1) · Spondylosis (1) · Tooth Loss (1)
Lindenhofgruppe AG (1) · University of Baghdad (1) · Xijing Hospital (1)
Iraq (1) · Switzerland (1)